Tj Biopharma Co., Ltd.

This study tests whether adding the experimental drug uliledlimab to standard immunotherapy (sintilimab) and chemotherapy can help people with advanced non-small cell lung cancer live longer without their cancer growing. About 150 adults who have not had prior treatment for their…

This study tests whether adding a new drug (uliledlimab) to an existing immunotherapy (toripalimab) works better than toripalimab alone or another standard drug (pembrolizumab) for people with advanced non-small cell lung cancer. Participants must have tumors with specific marker…